Showing results (491-500 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|April 15, 2024
In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cellsTolulope Peter Saliu, Nirwani Natasha Seneviratne, Mishal Faizan, et al.
In Silico Pharmacology|April 10, 2024
Exploring the anticancer potential of fluoro flavone analogues: insights from molecular docking and dynamics studies with Aurora Kinase BIpsa A Singh, Kiran Bharat Lokhande, K Venkateswara Swamy
In Silico Pharmacology|January 13, 2026
Quantum chemical and in silico-driven structural refinement of sulfanilamide for improved efficacy and safetySadia Sultana, Mahmudul Hasan Shuvo, Fahmida Zaman, et al.
In Silico Pharmacology|January 26, 2026
In silico functional and structural characterization of the hypothetical protein SRC1lrK2f from Alternaria alternataMd Imtiaz Ahamed, Sadia Islam Mim, Sarower Mahfuj, et al.
In Silico Pharmacology|January 30, 2026
Structure-based screening of marine carotenoids: fucoxanthin and its derivatives as potential inhibitors of the SARS-CoV-2 nucleocapsid phosphoproteinMurali Krishna Paidi, Shivaleela Biradar, T S Keshava Prasad
In Silico Pharmacology|January 30, 2026
Computational exploration of natural product inhibitors against mutant Plasmodium falciparum DHFR through pharmacophore modeling, docking, and MD simulationsDhrubajyoti Gogoi, Barbi Gogoi, Partha Pratim Dutta, et al.
In Silico Pharmacology|January 12, 2026
Unveiling the role of ZIKV NS4A mutants F4L and E8D through molecular docking and dynamics simulation: implications for MAVS-mediated immune evasionAfshan Salam, Usama Ilahi, Mian Hazrat Yousuf, et al.
In Silico Pharmacology|January 12, 2026
Mechanistic insights into the synergistic pharmacology of quercetin-kaempferol against SARS-CoV-2 infectionFarman Ali, Muhammad Zubair Saleem, Muhammad Mohsin, et al.
In Silico Pharmacology|January 19, 2026
In silico screening of IMPPAT-derived phytochemicals targeting ERG6 and drug resistance-associated proteins in drug-resistant Candida albicans: virtual screening and molecular dynamics using alphafold modelsAkshay Kisan Mundhe, Premanand Adaikalasamy, Reena Rajkumari Baskaran
In Silico Pharmacology|January 19, 2026
Therapeutic potential of Bergenia ciliata against lung cancer: an integrative molecular docking, ADMET, and molecular dynamics approachKrittika Mukherjee, Sounok Sengupta, Ajay Kumar Singh, et al.
Pageof 79